Health Economics›T-cell acute lymphoblastic leukemia pediatric›Pre-phase

Pre-phase

T-cell acute lymphoblastic leukemia pediatric · 1 regimen

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

Filters

Y-axis

Cost vs Efficacy

No data points — cost or PFS missing for current selection.

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
Methylprednisolone monotherapy Variant #02	—	R 2 802	23d	—	—	~1	~R 2 802 indirect	—

1 of 1 regimen shown